Yale Cancer Center

Yale Cancer Center is a collaboration between renowned cancer researchers and physicians @Yale and @SmilowCancer.

[Yale Cancer Center @YaleCancer]

More than 300 #clinicaltrials are currently open to new patients at Yale Cancer Center, offering a glimpse of advances in cancer treatment and how many modern #cancer drugs are tailored to patients based on biomarkers and genetic testing. “To get the most cutting-edge treatment, really clinical trials is a great option,” says Dr. Ian Krop, chief clinical research officer.
https://t.co/unojTwAdLT
@SmilowCancer

[Yale Cancer Center @YaleCancer]

Thanks to a longstanding collaboration between #VAConnecticut, @SmilowCancer and @YaleCancer, Veterans in Connecticut have access to highly specialized, multidisciplinary cancer care close to home.
https://t.co/FkJkxRfIhx
@SmilowCancer @YNHH @YaleMed

[Yale Cancer Center @YaleCancer]

As today's Future of Oncology Summit gathered leaders from across oncology, pharma, and biotech to shape the future of #cancer care, @DrEricWiner says: “It’s a time when we get scientists and people in industry and clinicians all together with the purpose of trying to come up with new therapies that will ultimately have an impact on our patients that we see every day."
➡️Watch: https://t.co/iPcUuC4Zfc
@SmilowCancer @YaleMed @YNHH

[Yale Cancer Center @YaleCancer]

Cancer research and treatment have entered a “golden age,” with #artificialintelligence helping accelerate scientific discoveries and creating new opportunities for biotechnology companies and investors, industry leaders said at the Future of Oncology Summit, hosted by @BioCT_org and @YaleCancer.
https://t.co/hQubc1Oqyy
@SmilowCancer @YNHH @YaleMed

[Yale Cancer Center @YaleCancer]

.@GovNedLamont stressed the importance of supporting an ecosystem and environment in CT for growth in #Biotech and life sciences @BioCT_org Future of Oncology Summit. @SmilowCancer @YaleMed @YNHH

[Yale Cancer Center @YaleCancer]

.@CliffordHudis discusses the positive impact #AI will continue to have on patient outcomes, scientific advances, and the medical profession in the coming years at the @BioCT_org Future of Oncology Summit. @ASCO @SmilowCancer

[Yale Cancer Center @YaleCancer]

Jodie Gillon @BioCT_org and @DrEricWiner welcome guests to the Future of Oncology Summit, urging collaboration and innovation among attendees from academia, industry, advocacy & government. @SmilowCancer @YaleMed @YNHH

[Yale Cancer Center @YaleCancer]

A Yale study led by @YangLiu_Yale presents a spatially-resolved epigenomic atlas of NF-PanNETs across tumor grades, providing new insights into epigenetic heterogeneity and tumor-stroma interactions & a foundation for future functional and clinical investigation.
https://t.co/acOLlk3oes
@SmilowCancer @YaleGICancers @iScience_CP @PamelaKunzMD @Cecchini_OncMD @yalepathology @NeurologyYale

[Yale Cancer Center @YaleCancer]

Hematologist and leader of the Yale Myeloma Team, @NataliaNeparid1 joins #YaleCancerAnswers tonight to talk in depth about CAR T-cell therapy and how it benefits patients with #myeloma.
🎧Listen live at 7:30pm @wnpr
💻Listen later @ApplePodcasts, @Spotify, @YouTube
@SmilowCancer @YaleHematology @YNHH

[Yale Cancer Center @YaleCancer]

.@jennkwanMDPhD will present two posters this weekend at @AHAScience #ScientificSessions26 on the topics of:
➡️Single-cell mapping → steroid-resistant ICI myocarditis
➡️Female predominant JAK-STAT signaling → sex-tailored cardioprotection
@SmilowCancer @YaleCardiology

[Yale Cancer Center @YaleCancer]

This afternoon at @AHAScience #ScientificSessions26, Dr. Jiarui Xing presents a digital poster on "Sex-Specific Anteroseptal Fibrotic Signatures on LGE-CMR Predict Future Cardiomyopathy in Cardio-Oncology."
@SmilowCancer @jennkwanMDPhD @YaleCardiology @Halene_lab

[Yale Cancer Center @YaleCancer]

“For a young person, when they get a #BRAF mutation, that is extremely likely to lead to #melanoma. But for an older person, it's less likely, though still possible,” @JeffTownsend. “This is important because there are therapies that target BRAF. It suggests they could be less effective in older patients than in younger ones.”
https://t.co/t4wvqQ8E2l
@SmilowCancer @ScienceAdvances @YaleSPH @OncoAlert

[Yale Cancer Center @YaleCancer]

A study led by @loraygs finds mortality and #frailty increase the longer an older adult remains in the hospital after surgery for non-metastatic pancreatic ductal adenocarcinoma #PDAC.
https://t.co/2VYfbhEBJC
@SmilowCancer @YaleGICancers @YaleCOPPER @ysphbiostat @cpgYALE @JGeriOnc

[Yale Cancer Center @YaleCancer]

Congratulations to Sam Abdelghany, PharmD, MHA, BCOP, named to the inaugural Class of 2026 #Fellow of @NCODAorg (FNCODA)! This distinction honors NCODA members whose sustained leadership, service, and meaningful contributions have helped shape the organization, strengthen the oncology community, and advance patient-centered cancer care.
@SmilowCancer @YNHH

[Yale Cancer Center @YaleCancer]

Registration is open for "Smilow Shares- #Fertility Preservation in the Setting of Cancer Care"
🗓️Wednesday, Nov. 11 at 6pm
💡Learn more about female & male fertility preservation, preserving reproductive potential, and the evolving landscape of fertility preservation care.
➡️RSVP https://t.co/hQAdNANrsa
@SmilowCancer @YaleObGynRes @vedangiri @DrRotker @YaleFertility

[Yale Cancer Center @YaleCancer]

Join the "41st Annual Ella T. Grasso Conference in Gynecologic Oncology"
📅Wednesday, Nov. 11 at 8:30am
📍Yale West Campus, West Haven
🦋This #CME conference brings together experts from across Yale to share updates and new discoveries in women’s health, including #endometriosis, #clinicaltrials, therapies for #ovariancancer, #fertility preservation, and much more.
➡️FMI + RSVP: https://t.co/lNoMTsAS9k
@SmilowCancer @YaleObGynRes

[Yale Cancer Center @YaleCancer]

Lisa Carberg shares an overview of a recent episode of #YaleCancerAnswers, featuring @PamelaKunzMD.
In this episode, Dr. Kunz discusses the latest advances and emerging developments in the treatment of #pancreaticcancer.
➡️https://t.co/cRram3mH9S
@SmilowCancer @YaleGICancers #pancreaticcancerawarenessmonth

[Yale Cancer Center @YaleCancer]

New data from @YaleThoracic shows patients with #NSCLC receiving neoadjuvant immune checkpoint inhibitors plus chemotherapy (ICI-CT) have improved survival - with excellent survival in patients with major pathological response (MPR) vs. those without.
https://t.co/bPax8lCUfh
@SmilowCancer @GavittWoodard @Sokim_33 @yalepathology @JTOonline

[Yale Cancer Center @YaleCancer]

.@MitchElliott18 and #breastcancer advocate, Adina Isenberg, discuss advancements in breast cancer treatment, including the role of personalized therapy and blood testing, and patient advocacy tonight at 7:30pm on #YaleCancerAnswers.
🎧Listen live @wnpr
💻Listen later @ApplePodcasts, @Spotify, @YouTube
@SmilowCancer @YaleBreast #bcsm